These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1493343)

  • 1. Bacteriology, drug stability and exchange of percutaneous delivery systems and antibacterial filters in long-term intrathecal infusion of opioid drugs and bupivacaine in "refractory" pain.
    Nitescu P; Hultman E; Appelgren L; Linder LE; Curelaru I
    Clin J Pain; 1992 Dec; 8(4):324-37. PubMed ID: 1493343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain.
    Nitescu P; Sjöberg M; Appelgren L; Curelaru I
    Clin J Pain; 1995 Mar; 11(1):45-62. PubMed ID: 7540439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps.
    Dahm P; Nitescu P; Appelgren L; Curelaru I
    Clin J Pain; 1998 Mar; 14(1):4-16. PubMed ID: 9535309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
    Nitescu P; Dahm P; Appelgren L; Curelaru I
    Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients.
    Sjöberg M; Karlsson PA; Nordborg C; Wallgren A; Nitescu P; Appelgren L; Linder LE; Curelaru I
    Anesthesiology; 1992 Feb; 76(2):173-86. PubMed ID: 1736693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes.
    Wulf H; Gleim M; Mignat C
    J Pain Symptom Manage; 1994 Jul; 9(5):308-11. PubMed ID: 7963782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hygienic relations and stability of drugs in peridural long-term infusion with implanted or external pumps].
    Müller H; Biscoping J; Gips H; Tilkes F; Strunz P; Hempelmann G
    Anaesthesist; 1985 May; 34(5):247-51. PubMed ID: 3927767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study.
    Goucke CR; Dusci LJ; Van Leeuwen S; Fairclough D; Ilett KF
    Pain Med; 2010 Nov; 11(11):1612-8. PubMed ID: 21029352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.
    Sjöberg M; Nitescu P; Appelgren L; Curelaru I
    Anesthesiology; 1994 Feb; 80(2):284-97. PubMed ID: 8311311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system.
    Hildebrand KR; Elsberry DD; Deer TR
    Clin J Pain; 2001 Sep; 17(3):239-44. PubMed ID: 11587115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of long-term spinal opioid treatment in advanced cancer patients.
    Mercadante S
    Pain; 1999 Jan; 79(1):1-13. PubMed ID: 9928770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine.
    Krames ES; Lanning RM
    J Pain Symptom Manage; 1993 Nov; 8(8):539-48. PubMed ID: 7525783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases.
    Van Dongen RTM; Crul BJP; De Bock M
    Pain; 1993 Oct; 55(1):119-123. PubMed ID: 8278204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal infusion of bupivacaine with or without buprenorphine relieved intractable pain in three patients with vertebral compression fractures caused by osteoporosis.
    Dahm PO; Nitescu PV; Appelgren LK; Curelaru ID
    Reg Anesth Pain Med; 1999; 24(4):352-7. PubMed ID: 10445776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
    Robert J; Sorrieul J; Rossignol E; Beaussart H; Kieffer H; Folliard C; Dupoiron D; Devys C
    Int J Pharm Compd; 2017; 21(4):347-351. PubMed ID: 28719378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive systemic sclerosis: intrathecal pain management.
    Lundborg CN; Nitescu PV; Appelgren LK; Curelaru ID
    Reg Anesth Pain Med; 1999; 24(1):89-93. PubMed ID: 9952101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
    Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
    Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain.
    Appelgren L; Janson M; Nitescu P; Curelaru I
    Anesthesiology; 1996 Feb; 84(2):256-72. PubMed ID: 8602655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients.
    Wagemans MF; van der Valk P; Spoelder EM; Zuurmond WW; de Lange JJ
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):1033-8. PubMed ID: 9311403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.